Showing results (731-740 of 2,747) with videos related to

Sort By:
Pageof 275
Clinical and Experimental Nephrology|July 1, 2015
Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuriaHiroyuki Komatsu, Yuji Sato, Tetsu Miyamoto, et al.
Clinical and Experimental Nephrology|July 10, 2015
Efficacy and safety of eculizumab in childhood atypical hemolytic uremic syndrome in JapanNaoko Ito, Hiroshi Hataya, Ken Saida, et al.
Clinical and Experimental Nephrology|June 16, 2015
Mitochondrial proteomes of porcine kidney cortex and medulla: foundation for translational proteomicsZdenek Tuma, Jitka Kuncova, Jan Mares, et al.
Clinical and Experimental Nephrology|June 18, 2015
Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial)Enyu Imai, Shoichi Maruyama, Masaomi Nangaku, et al.
Clinical and Experimental Nephrology|February 4, 2018
Progressive kidney disease may not alter the association of hyponatremia with mortalityLadan Golestaneh, Joel Neugarten, Frederick Kaskel, et al.
Clinical and Experimental Nephrology|March 18, 2018
Imaging of bilateral Ask-Upmark kidneyHiroshi Komatsu, Teruki Aoi, Ichiro Yamazoe
Clinical and Experimental Nephrology|January 21, 2018
Clinical features in a series of 258 Japanese pediatric patients with thrombotic microangiopathyAkira Ashida, Hideki Matsumura, Toshihiro Sawai, et al.
Clinical and Experimental Nephrology|March 24, 2018
Hypertension and its severity in children with steroid sensitive nephrotic syndrome during remissionSwasti Keshri, Shobha Sharma, Neha Agrawal, et al.
Clinical and Experimental Nephrology|October 27, 2017
Opacity of big toenail predicts poor prognosis in patients with end-stage renal disease on hemodialysisOsamu Soma, Shingo Hatakeyama, Teppei Matsumoto, et al.
Clinical and Experimental Nephrology|January 27, 2018
Uric acid-lowering and renoprotective effects of topiroxostat, a selective xanthine oxidoreductase inhibitor, in patients with diabetic nephropathy and hyperuricemia: a randomized, double-blind, placebo-controlled, parallel-group study (UPWARD study)Takashi Wada, Tatsuo Hosoya, Daisuke Honda, et al.
Pageof 275